Editorial Note: Alan Moore, 28, has an MA from George Mason University and previously served as press secretary for the Tancredo for President Committee and the Freedom Alliance. He now works for the Heritage Foundation at Townhall.com
I volunteered for the O’Donnell campaign in 2008. I am not owed any money nor have I ever received payment from either the O’Donnell or Mike Castle campaigns. Working with her for an election cycle taught me one indisputable fact: Christine O’Donnell is not deserving of ever holding elected office and her nomination will be nothing short of catastrophic to the Tea Party movement. The implications of her nomination for conservatives everywhere are enormous. Continue reading
48 hours before Delaware Republicans go to the polls, Christine O'Donnell has pulled into the lead in the Republican Senate primary.
A Public Policy Polling survey released on Sunday night indicates a major upset is possible in Delaware’s U.S. Senate primary on Tuesday. The survey has conservative Christine O’Donnell defeating moderate Rep. Mike Castle in the primary by a 47% to 44% margin. Castle has a 69% to 21% lead with moderate voters but they only make up 33% of the likely primary electorate. O’Donnell has a 62% to 31% lead with conservatives which is more than enough to propel her to victory in less than 48 hours.
The O’Donnell surge was a shock to political pundits in both parties, and their reactions are listed below. Practically all of them agree that while O’Donnell could win on Tuesday it would be difficult for her to win a general election. She has such a controversial background that Democrats would not have a difficult time increasing her negative ratings. The recent O’Donnell surge was fueled by the endorsements she just received from Sarah Palin, Sen. Jim DeMint (R-SC) and the National Rifle Association. Castle is probably the most liberal Republican Senate candidate this year, and the major strike against him his vote for cap and trade. Castle opposed the Stimulus and is in favor of repealing Obamacare. Continue reading